Monkeying around with cardiac progenitors: hope for the future.


Multipotent cardiovascular progenitor cells derived from ES cells or induced pluripotent stem (iPS) cells are an intriguing source for stem cell-based therapies for congenital and acquired heart diseases. From a clinical perspective, the ideal cardiac progenitor cells are those that can proliferate, survive, and differentiate into multiple mature cardiac… (More)
DOI: 10.1172/JCI42643


1 Figure or Table

Slides referencing similar topics